In view of the Egyptian Drug Authority’s (EDA) membership in the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), and its active role in drafting international guidelines, and within the framework of the EDA’s commitment to staying abreast of modern scientific developments—ensuring the availability of advanced medical products while maintaining the highest standards of quality, safety, and efficacy, and fostering regulatory convergence.

The Egyptian Drug Authority (EDA) announces the publication of the following draft guideline for public consultation:

We are pleased to receive your feedback via the "Public Consultation Form" at the following email address:ct.scts@edaegypt.gov.eg

This initiative aims to provide an opportunity for all stakeholders to participate by sharing their views and observations.